Vertex pharmaceuticals stock price

Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Vertex Pharmaceuticals against related stocks  Based on 23 analysts offering 12 month price targets for Vertex Pharmaceuticals in the last 3 months. The average price target is $267.76 with a high forecast of 

Vertex Pharmaceuticals stock price history + stock price today + stock chart + seasonality chart + earnings + dividends + century-to-date Dogs of the Dow beating  Real-time share price updates and latest news for Vertex Pharmaceuticals Inc ( NASDAQ:VRTX). Compare across sectors, industries & regions. 5 days ago Share. Stock. VRTX. Price as of: Mar 24, 2:00 PM. $238.31 -3.85 -1.59%. Industry . Specialized Health Services  24 Mar 2020 Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock's existing status and the future  13 Mar 2020 Vertex Pharmaceuticals Incorporated (VRTX) stock is trading at an increase of $4.33, or 2.12% from the previous closing price of $204.06. Vertex Pharmaceuticals Incorporated [VRTX] stock Initiated by Barclays analyst, price target now $271. By. Caleb Clifford. -. March 13, 2020. Facebook · Twitter. Vertex Pharmaceuticals - VRTX - Stock Price & News | The ...

Stock analysis for Vertex Pharmaceuticals Inc (VRTX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Vertex Pharmaceuticals Incorporated Common Stock (VRTX ... VRTX Real Time Stock Quote - Get Vertex Pharmaceuticals Incorporated Common Stock (VRTX) last sale data in real-time at NASDAQ.com. Vertex Pharmaceuticals Stock Forecast: up to 248.643 USD ... Historical index on US Stock Market : B+ "Should I invest in Vertex Pharmaceuticals stock?" "Should I trade "VRTX" stock today?" According to our live Forecast System, Vertex Pharmaceuticals Incorporated stock is a good long-term (1-year) investment*. "VRTX" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. Vertex Pharmaceuticals Inc. - NASDAQ:VRTX - Stock Quote ... View detailed financial information, real-time news, videos, quotes and analysis on Vertex Pharmaceuticals Inc. (NASDAQ:VRTX). Explore commentary … VRTX Vertex Pharmaceuticals Incorporated — Stock Price and ...

Home | Vertex Pharmaceuticals

Vertex Pharmaceuticals - VRTX - Stock Price & News | The ...

Vertex Pharmaceuticals Incorporated Stock Price Chart ...

Home | Vertex Pharmaceuticals Vertex creates new possibilities in medicine to cure diseases and improve people's lives. We work with leading researchers, doctors, public health experts and other collaborators who share our vision for transforming the lives of people with serious diseases, their families and society. Vertex Pharmaceuticals Inc : VRTX Stock Price Quote at ...

Vertex Pharmaceuticals Incorporated [VRTX] stock Initiated by Barclays analyst, price target now $271. By. Caleb Clifford. -. March 13, 2020. Facebook · Twitter.

Vertex Pharmaceuticals - VRTX - Stock Price & News | The ... Apr 03, 2020 · Real time Vertex Pharmaceuticals (VRTX) stock price quote, stock graph, news & analysis. Vertex Pharmaceuticals Incorpor (VRTX) Stock Price, Quote ... Find the latest Vertex Pharmaceuticals Incorpor (VRTX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Vertex Pharmaceuticals is the IBD Stock Of The Day as VRTX stock parries coronavirus worries on enthusiasm for its new cystic fibrosis treatment.. X. Last year, the biotech company launched Vertex Pharmaceuticals Incorporated Stock Price Chart ... Apr 26, 2019 · Vertex Pharmaceuticals Incorporated live price charts and stock performance over time. Use technical analysis tools such as candles & Fibonacci to generate different instrument comparisons. Vertex Pharmaceuticals Is A Strong Buy - Vertex ... Nov 18, 2019 · VRTX has earned quite a lot of traction driven by the rapid approval of its triple combo Cystic Fibrosis regimen, Trikafta. VRTX delivered a stellar performance in the third quarter of 2019